Philadelphia, Pennsylvania--(Newsfile Corp. - February 5, 2025) - Current Aldeyra shareholders who have continuously held Aldeyra Therapeutics ... Grabar Law Office is investigating claims ...

The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...

The newly formed company will be named Decoy Therapeutics. This proposed transaction is expected to facilitate multiple value-creating inflection points with Decoy’s pipeline of peptide ...

However, Wall Street's enthusiasm for Summit Therapeutics appears to be justified. If ivonescimab fulfills its potential, Summit should be worth a lot more within a few years than it is today.

The upstart, clinical stage biotech company Viking Therapeutics, Inc. (NASDAQ ... Trump’s most pressing concerns in his early days in office seem to be tackling issues with immigration ...

Text description provided by the architects. In this workspace, Shang Interior Architects breaks away from the rigid norms of traditional office layouts by deconstructing and reorganizing the ...

Mirati Therapeutics is the subject of takeover speculation in the biopharma sector once again, as it waits for the FDA's decision on its KRAS inhibitor adagrasib in non-small cell lung cancer (NSCLC).

Mirati Therapeutics’ hopes of an EU approval for its KRAS inhibitor Krazati in the EU have been thrown into disarray after the EMA’s human medicines committee rejected the drug as a lung ...

As we step into 2025, interior design is becoming more personal than ever. Gone are the days of standard builder-grade finishes, stark white walls, and thoughtless choices. This year is all about ...

Microsoft’s Office has been an iconic product, with billions relying on it to accomplish their work. However, in 2022, the brand made a surprising decision to rebrand itself. Microsoft Office ...